PreprintAll rights reservedbioRxiv
The RNA modification N6-methyladenosine restrains SIRPα to license myeloid efferocytosis in atherosclerosis
- 1University of California, Los Angeles
Related
- Regulatory roles and molecular mechanisms of N6-methyladenosine (m6A) modification in ischemia-reperfusion injury
- Posttranslational Modification Cross-Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis.
- Efferocytosis-Related Transcriptional Dysregulation in Hidradenitis Suppurativa Lesional Macrophages: A Multi-Cohort Single-Cell and Bulk Transcriptomic Study
- SIK2 antagonizes postinfarction cardiac repair by driving macrophage proinflammatory and impairing efferocytosis
- Proximal Tubule-to-Proximal Tubule Efferocytosis: Gusb Prevents Efferocytosis Failure and Polyphagolysosomal Overload in CAZ-AVI-Induced Acute Kidney Injury
BibTeX
@misc{kallapur2026modification,
title = {{The RNA modification N6-methyladenosine restrains SIRPα to license myeloid efferocytosis in atherosclerosis}},
author = {A. Kallapur and X. Li and E. Rodriguez-Sanchez and Z. Zhang and A. Sinha and L. Cheng and D. Wang and J. Gu and J. Kim and X. Wu and W. Li and Y. Cui and X. He and C. He and T. Sallam},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.19.749544},
url = {https://www.biorxiv.org/content/10.64898/2026.09.19.749544v1},
}
RIS
TY - UNPB
TI - The RNA modification N6-methyladenosine restrains SIRPα to license myeloid efferocytosis in atherosclerosis
AU - A. Kallapur
AU - X. Li
AU - E. Rodriguez-Sanchez
AU - Z. Zhang
AU - A. Sinha
AU - L. Cheng
AU - D. Wang
AU - J. Gu
AU - J. Kim
AU - X. Wu
AU - W. Li
AU - Y. Cui
AU - X. He
AU - C. He
AU - T. Sallam
PY - 2026
DA - 2026/09/19
PB - bioRxiv
DO - 10.64898/2026.09.19.749544
UR - https://www.biorxiv.org/content/10.64898/2026.09.19.749544v1
ER -